Blomen, Chiara L.
Pott, Aliaksandra
Volk, Alexander E.
Budäus, Lars
Witzel, Isabell https://orcid.org/0000-0002-8734-4521
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 4 April 2021
Accepted: 7 September 2021
First Online: 11 October 2021
Competing interests
: I.W. has no conflict of interest concerning the presented analysis, she received speaker’s honoraria outside this work from Amgen, Astra Zeneca, MSD, Novartis, Pierre Fabre Pharme, Pfizer, Roche, Sanofi-Aventis. All other authors declare that they have no competing interests.